Congress urges DOJ, Treasury to examine drug companies aiming to turn opioid settlements into tax breaks
This post was originally published on this siteWith billion-dollar deductions, House members say, businesses may be trying to “shift the financial burden of the damage they have caused to American taxpayers.”